Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −333 2,667
2021-08-10 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −1,468 30,819
2021-07-19 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +333 $5.17 $2K 333
2021-07-19 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion +1,467 $0.77 $1K 1,800
2021-07-19 Echerd Margaret SVP, Principal Accntng Officer Sale −1,800 $8.00 $14K 0
2021-07-19 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −333 3,000
2021-07-19 Echerd Margaret SVP, Principal Accntng Officer Exercise or conversion · Stock Option (right to buy) −1,467 32,287
2021-06-18 Finney Michael J. Director Exercise or conversion +9,000 $0.68 $6K 461,572
2021-06-18 Finney Michael J. Director Exercise or conversion +12,700 $0.68 $9K 474,272
2021-06-18 Finney Michael J. Director Option exercise +181,818 $1.10 $200K 656,090
2021-06-18 Finney Michael J. Director Exercise or conversion · Stock Option (right to buy) −9,000 0
2021-06-18 Finney Michael J. Director Exercise or conversion · Stock Option (right to buy) −12,700 0
2021-06-18 Finney Michael J. Director Option exercise · Common Stock Purchase Warrant −181,818 0
2021-06-16 Wheadon David E. Director Grant or award · Stock Option (right to buy) +65,700 65,700
2021-06-16 Yedid Robert A. Director Grant or award · Stock Option (right to buy) +15,097 15,097
2021-06-16 WILSON KAREN J Director Grant or award · Stock Option (right to buy) +15,097 15,097
2021-06-16 Finney Michael J. Director Grant or award · Stock Option (right to buy) +15,097 15,097
2021-06-16 Davis Todd C Director Grant or award · Stock Option (right to buy) +15,097 15,097
2021-06-16 Echerd Margaret SVP, Principal Accntng Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2021-06-16 Tucker Sean SVP, Chief Scientific Officer Grant or award · Stock Option (right to buy) +100,000 100,000

Page 12 of 23 · 442 trades